- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07883473
Pudendal Nerve Block for Pain Relief During Episiotomy Repair
Pudendal Nerve Block for Pain Relief During Episiotomy Repair: A Randomized Controlled Trial
Episiotomy is a surgical cut made in the perineum, the area between the vagina and anus, during vaginal childbirth. Repairing an episiotomy can cause pain, and adequate pain relief is important for maternal comfort during and after delivery.
This study will compare two methods of providing anesthesia during episiotomy repair in women undergoing vaginal delivery with a mediolateral episiotomy at the Department of Maternal and Child Health (MCH), Pakistan Institute of Medical Sciences (PIMS), Islamabad, Pakistan.
A total of 80 eligible women will be enrolled and randomly assigned in equal numbers to two groups. The intervention group will receive a bilateral pudendal nerve block in addition to routine episiotomy repair and standard postpartum pain relief. The control group will receive conventional local anesthetic infiltration around the episiotomy area, along with routine repair and standard postpartum pain relief.
Pain will be assessed using a 100-mm Visual Analogue Scale (VAS), on which 0 represents no pain and 100 represents the worst imaginable pain. Pain will be assessed during episiotomy repair and at 1, 3, and 6 hours after delivery.
The study will also compare the need for additional pain medication, pain during sitting and walking, patient comfort and satisfaction, the duration of episiotomy repair, the need for additional local anesthetic, and complications associated with the procedures.
The aim is to determine whether pudendal nerve block provides better pain relief during episiotomy repair and improves early postpartum comfort compared with conventional local anesthetic infiltration.
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
Episiotomy is a surgical incision of the perineum performed during vaginal delivery and may be associated with pain during repair and in the early postpartum period. Conventional local perineal infiltration is commonly used to provide anesthesia during episiotomy repair; however, adequate pain relief may not always be achieved.
The pudendal nerve supplies sensory innervation to the vulva, lower vagina, perineum, and anus. Pudendal nerve block is a regional anesthetic technique that may provide effective analgesia during episiotomy repair. This study will evaluate the effectiveness of pudendal nerve block compared with conventional local perineal infiltration in women undergoing mediolateral episiotomy at the Department of Maternal and Child Health, Pakistan Institute of Medical Sciences (MCH PIMS), Islamabad.
Eligible women aged 18 years or older who undergo vaginal delivery with mediolateral episiotomy will be recruited after eligibility assessment and informed consent. Participants will be randomly allocated to one of two groups. The intervention group will receive bilateral pudendal nerve block using 2% lidocaine, in addition to routine episiotomy repair and standard postpartum analgesia. The control group will receive conventional local perineal infiltration according to the institutional protocol. Both groups will receive routine episiotomy repair and standard postpartum analgesia.
Pain intensity will be assessed using a 100-mm Visual Analogue Scale during episiotomy repair and at 1, 3, and 6 hours postpartum. Additional assessments will include the need for rescue analgesia, pain during sitting and walking, patient-reported comfort and satisfaction, duration of repair, requirement for additional local anesthetic, and the success or failure of the nerve block. Adverse events and complications associated with the procedures will also be documented.
The study aims to determine whether pudendal nerve block improves pain relief during episiotomy repair and early postpartum comfort compared with conventional local perineal infiltration. The findings may contribute to the local evidence base for pain management during episiotomy repair.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Zeenat Usman/Medical officier, MS obstetrics and gyanecology
- Telefonnummer: +923315333910
- E-Mail: usmanbut2@gmail.com
Studieren Sie die Kontaktsicherung
- Name: Sobia Luqman/Assisstant Professor, FCPS obstetrics and gyane
- Telefonnummer: +923348626904
- E-Mail: sobialuqman8@gmail.com
Studienorte
-
-
ICT
-
Islamabad, ICT, Pakistan, 04485
- Department of Maternal and Child Health (MCH), Pakistan Institute of Medical Sciences (PIMS)
-
Kontakt:
- Zeenat Usman, MS obstetrics and Gyanecology
- Telefonnummer: +923315333910
- E-Mail: usmanbut2@gmail.com
-
Kontakt:
- Sobia Luqman, FCPS obstetrics and gyanecolog
- Telefonnummer: +923348626904
- E-Mail: sobialuqman8@gmail.com
-
Hauptermittler:
- Zeenat Usman, Ms Obsterics and gyanecology
-
Unterermittler:
- Sobia Luqman, FCPS-obstertics and gyanecolog
-
Unterermittler:
- Lubaba Tahir
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Women aged 18 years or older
- Singleton pregnancy
- Vaginal delivery at MCH PIMS
- Requirement for mediolateral episiotomy
- Clinically uncomplicated episiotomy requiring routine repair
- Ability to understand the study information and provide written informed consent
Exclusion Criteria:
- Allergy or contraindication to the proposed local anesthetic
- Known coagulation disorder or significant bleeding tendency
- Local infection at the proposed injection site
- Associated third- or fourth-degree perineal tear
- Extensive vaginal or cervical laceration requiring additional anesthesia
- Major postpartum hemorrhage or another major postpartum complication requiring urgent management
- Chronic pelvic or perineal pain, or regular use of analgesic medication before delivery
- Inability to understand the pain assessment scale or provide informed consent
- Failed pudendal nerve block despite appropriate technique
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Pudendal Nerve Block Group
Participants will receive bilateral pudendal nerve block using 2% lidocaine, 2 mL, as specified in the study protocol. The procedure will be performed by an appropriately trained obstetrician or anesthetist using a standardized technique. Routine episiotomy repair and standard postpartum analgesia will also be provided. |
Bilateral pudendal nerve block performed using the standardized technique specified in the study protocol, with the local anesthetic described in the protocol (2% lidocaine, 2 mL). The procedure will be performed by an appropriately trained obstetrician or anesthetist, in addition to routine episiotomy repair and standard postpartum analgesia. Local anesthetic administered for bilateral pudendal nerve block at a dose of 2 mL, as specified in the study protocol. |
|
Aktiver Komparator: Conventional Local Infiltration Group
Participants will receive conventional local perineal infiltration anesthesia according to the standard MCH PIMS episiotomy-repair protocol. Routine episiotomy repair and standard postpartum analgesia will be provided. |
Conventional local anesthetic infiltration around the episiotomy site according to the standard MCH PIMS episiotomy-repair protocol. Routine episiotomy repair and standard postpartum analgesia will also be provided. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Pain intensity during episiotomy repair
Zeitfenster: During episiotomy repair
|
Pain intensity will be measured using a 100-mm Visual Analogue Scale (VAS), where 0 represents no pain and 100 mm represents the worst imaginable pain. Pain will be assessed at predefined stages during episiotomy repair, including after anesthesia administration, at commencement of repair, during repair, and at completion of repair. |
During episiotomy repair
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Postpartum pain intensity
Zeitfenster: 1, 3, and 6 hours postpartum
|
pain intensity measured using a 100-mm Visual Analogue Scale (VAS), where 0 represents no pain and 100 represents the worst imaginable pain. |
1, 3, and 6 hours postpartum
|
|
Requirement for rescue analgesia
Zeitfenster: First 6 hours postpartum
|
Proportion of participants requiring additional analgesic medication for inadequate episiotomy-related pain relief. |
First 6 hours postpartum
|
|
Patient satisfaction with pain management
Zeitfenster: 1-6 hours postpartum
|
Patient satisfaction with pain management assessed using a 5-point Likert scale, ranging from very dissatisfied to very satisfied. |
1-6 hours postpartum
|
Mitarbeiter und Ermittler
Publikationen und hilfreiche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- F.1-1/2015/ERB/SZABMU/1634
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
De-identified individual participant data collected during this study will not be shared with researchers outside the study team. Study data will be used for the planned analyses and reporting of study findings.
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .